Clinical Laserthermia Systems
5.19 SEK
-39.23 %
Less than 1K followers
CLS B
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-39.23 %
-28.81 %
-24.56 %
-23.68 %
+2.57 %
+39.52 %
-87.72 %
-98.27 %
-97.90 %
Clinical Laserthermia Systems operates in the medical technology sector. The company's vision is to develop and streamline the treatment of solid cancer tumors, where the company is a seller of sterile patient kits. The products are used in various cancer treatments such as in the treatment of malignant melanoma, as well as cancer of the lungs, liver and pancreas. The company was founded in 2006 and has its headquarters in Lund.
Read moreMarket cap
161.75M SEK
Turnover
7.95M SEK
Revenue
17.49M
EBIT %
-164.75 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
12/5
2026
Interim report Q1'26
14/8
2026
Interim report Q2'26
13/11
2026
Interim report Q3'26
All
Press releases
ShowingAll content types
CLS: Clinical Laserthermia Systems AB publishes Year-end report January - December 2025
CLS: TRANBERG[®] Thermal Therapy System installed at Andros Clinics for Launch of Ultrasound-Guided Focal Laser Ablation Program in The Netherlands
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools